Rural Health
Resources by Topic: Pharmacy and prescription drugs
RHC COVID-19 Program Updates
Recording of an August 18, 2022, webinar discussing and answering questions about COVID-19 therapeutics, testing and mitigation, vaccine, and provider relief programs available to Rural Health Clinics (RHCs). Part of the Rural Health Clinic Technical Assistance Series.
Additional links: Presentation Slides, Transcript
Date: 08/2022
Type: Video/Multimedia
Sponsoring organization: National Association of Rural Health Clinics
view details
Recording of an August 18, 2022, webinar discussing and answering questions about COVID-19 therapeutics, testing and mitigation, vaccine, and provider relief programs available to Rural Health Clinics (RHCs). Part of the Rural Health Clinic Technical Assistance Series.
Additional links: Presentation Slides, Transcript
Date: 08/2022
Type: Video/Multimedia
Sponsoring organization: National Association of Rural Health Clinics
view details
Increasing Access to Routine Child Immunizations: State Approaches for Increasing Pharmacy Enrollment in the VFC Program
Discusses how increasing pharmacy participation in the Vaccines for Children Program (VFC) can promote access to childhood vaccinations and reduce disparities. Outlines steps states can take to identify and address barriers to enrollment, including examining reimbursement policies, aligning program requirements with Centers for Disease Control and Prevention (CDC) requirements, addressing common provider misconceptions about the VFC program, and addressing pediatrician concerns.
Date: 07/2022
Type: Document
Sponsoring organization: National Academy for State Health Policy
view details
Discusses how increasing pharmacy participation in the Vaccines for Children Program (VFC) can promote access to childhood vaccinations and reduce disparities. Outlines steps states can take to identify and address barriers to enrollment, including examining reimbursement policies, aligning program requirements with Centers for Disease Control and Prevention (CDC) requirements, addressing common provider misconceptions about the VFC program, and addressing pediatrician concerns.
Date: 07/2022
Type: Document
Sponsoring organization: National Academy for State Health Policy
view details
North Carolina Medication Assistance Program: 2022 Profile
Fact sheet on funding, performance measures, and economic impact of the North Carolina Medication Assistance Program. Includes a county-level map showing Medication Assistance Program sites as of June 2022.
Date: 06/2022
Type: Document
Sponsoring organization: North Carolina Office of Rural Health
view details
Fact sheet on funding, performance measures, and economic impact of the North Carolina Medication Assistance Program. Includes a county-level map showing Medication Assistance Program sites as of June 2022.
Date: 06/2022
Type: Document
Sponsoring organization: North Carolina Office of Rural Health
view details
MiCare Champion Cast: How 340B Benefits Rural Michigan
Podcast that explains the 340B drug pricing program and its impact on rural Michigan. Presents a discussion with stakeholders from the Mackinac Straits Health System which includes a Critical Access Hospital, Rural Health Clinic, and other healthcare facilities.
Date: 06/2022
Type: Audio
Sponsoring organization: Michigan Health & Hospital Association
view details
Podcast that explains the 340B drug pricing program and its impact on rural Michigan. Presents a discussion with stakeholders from the Mackinac Straits Health System which includes a Critical Access Hospital, Rural Health Clinic, and other healthcare facilities.
Date: 06/2022
Type: Audio
Sponsoring organization: Michigan Health & Hospital Association
view details
BuchananCares Program: A Team-based Care Pilot Led by a Rural Community Hospital and Local Pharmacist
Describes BuchananCares, a collaboration among health professionals from the Appalachian College of Pharmacy, Buchanan General Hospital in rural Virginia, and the Virginia Department of Health. Designed to reduce patient readmissions and improve medication use for patients with COPD, diabetes, heart failure, and pneumonia.
Date: 06/2022
Type: Document
Sponsoring organization: Community Preventive Services Task Force
view details
Describes BuchananCares, a collaboration among health professionals from the Appalachian College of Pharmacy, Buchanan General Hospital in rural Virginia, and the Virginia Department of Health. Designed to reduce patient readmissions and improve medication use for patients with COPD, diabetes, heart failure, and pneumonia.
Date: 06/2022
Type: Document
Sponsoring organization: Community Preventive Services Task Force
view details
Prescribing Alzheimer's Disease Treatments by Provider Type and Geographic Region: A Comparison among Physicians, Nurse Practitioners, and Physician Assistants
Study examining prescriptions for Alzheimer's Disease (AD) medications by provider type and geographic regions, including non-metro and a range of metro settings. Analysis is based on commercial and Medicare supplemental claims data.
Author(s): Jenny Y. Park, David L. Veenstra, Christopher J. Wallick, Zachary A. Marcum
Citation: BMC Geriatrics, 22, 522
Date: 06/2022
Type: Document
view details
Study examining prescriptions for Alzheimer's Disease (AD) medications by provider type and geographic regions, including non-metro and a range of metro settings. Analysis is based on commercial and Medicare supplemental claims data.
Author(s): Jenny Y. Park, David L. Veenstra, Christopher J. Wallick, Zachary A. Marcum
Citation: BMC Geriatrics, 22, 522
Date: 06/2022
Type: Document
view details
MedPAC Report to the Congress: Medicare and the Health Care Delivery System, June 2022
Evaluates Medicare payment issues and provides recommendations to the U.S. Congress. Chapter 2 presents a report on access to care for beneficiaries in Medically Underserved Areas (MUAs), who are dually eligible for Medicare and Medicaid, or have multiple chronic conditions. Also includes chapters on alternative payment models, safety net providers, the cost of drugs covered under Medicare Part B, the accuracy of Medicare Advantage payments, the alignment of fee-for-service payment rates across ambulatory settings, and segmentation in the stand-alone Part D plan market.
Date: 06/2022
Type: Document
Sponsoring organization: Medicare Payment Advisory Commission
view details
Evaluates Medicare payment issues and provides recommendations to the U.S. Congress. Chapter 2 presents a report on access to care for beneficiaries in Medically Underserved Areas (MUAs), who are dually eligible for Medicare and Medicaid, or have multiple chronic conditions. Also includes chapters on alternative payment models, safety net providers, the cost of drugs covered under Medicare Part B, the accuracy of Medicare Advantage payments, the alignment of fee-for-service payment rates across ambulatory settings, and segmentation in the stand-alone Part D plan market.
Date: 06/2022
Type: Document
Sponsoring organization: Medicare Payment Advisory Commission
view details
Expanded Naloxone Distribution to Reduce Rural Opioid Overdose Mortality
Discusses a study on the effect community-based and pharmacy-initiated naloxone distribution has had on rates of rural opioid overdose mortality. Highlights an intervention that expands naloxone access points in rural communities and pharmacies in addition to traditional provider-based treatment.
Date: 05/2022
Type: Document
Sponsoring organization: University of Vermont Center on Rural Addiction
view details
Discusses a study on the effect community-based and pharmacy-initiated naloxone distribution has had on rates of rural opioid overdose mortality. Highlights an intervention that expands naloxone access points in rural communities and pharmacies in addition to traditional provider-based treatment.
Date: 05/2022
Type: Document
Sponsoring organization: University of Vermont Center on Rural Addiction
view details
April 2022 MedPAC Meeting Transcript
Transcript from the Medicare Payment Advisory Commission's (MedPAC) April 2022 meeting. Covers high prices of drugs covered under Medicare Part B, initial findings from MedPAC's analysis of Part D data on drug rebates and discounts, segmentation in the stand-alone Part D prescription drug plan market, leveraging Medicare policies to address social determinants of health, an approach to streamline and harmonize Medicare's portfolio of alternative payment models, and aligning fee-for-service payment rates across ambulatory settings. Includes rural references throughout.
Date: 04/2022
Type: Document
Sponsoring organization: Medicare Payment Advisory Commission
view details
Transcript from the Medicare Payment Advisory Commission's (MedPAC) April 2022 meeting. Covers high prices of drugs covered under Medicare Part B, initial findings from MedPAC's analysis of Part D data on drug rebates and discounts, segmentation in the stand-alone Part D prescription drug plan market, leveraging Medicare policies to address social determinants of health, an approach to streamline and harmonize Medicare's portfolio of alternative payment models, and aligning fee-for-service payment rates across ambulatory settings. Includes rural references throughout.
Date: 04/2022
Type: Document
Sponsoring organization: Medicare Payment Advisory Commission
view details
2021 340B Health Annual Survey: 340B Continues to Support Essential Programs and Services in the Face of Significant Financial Stress on Hospitals
Summarizes the results of an October - December 2021 survey of 510 hospitals, including small and rural hospitals, that participate in the 340B drug pricing program. Describes how these hospitals utilize their savings from the 340B program to benefit patients. Discusses the importance of the program to Critical Access Hospitals, Disproportionate Share Hospitals, and other safety-net facilities. Explores the potential effects of additional cuts to the 340B program.
Date: 04/2022
Type: Document
Sponsoring organization: 340B Health
view details
Summarizes the results of an October - December 2021 survey of 510 hospitals, including small and rural hospitals, that participate in the 340B drug pricing program. Describes how these hospitals utilize their savings from the 340B program to benefit patients. Discusses the importance of the program to Critical Access Hospitals, Disproportionate Share Hospitals, and other safety-net facilities. Explores the potential effects of additional cuts to the 340B program.
Date: 04/2022
Type: Document
Sponsoring organization: 340B Health
view details